About
MitoImmune Therapeutics develops therapeutics targeting mitochondrial dysfunction and immune system regulation for treating autoimmune diseases and inflammatory conditions.
Explore MitoImmune Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.